Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 7,028 | 11,997 | 5,304 | 8,498 | 3,219 |
| Cost of Goods | 2,625 | 2,315 | 1,958 | 2,138 | 1,201 |
| Gross Profit | 4,403 | 9,682 | 3,346 | 6,360 | 2,018 |
| Operating Expenses | 5,576 | 6,114 | 6,838 | 5,436 | 5,114 |
| Operating Income | -548 | 3,883 | -2,534 | 1,062 | -2,895 |
| Interest Expense | 31 | 124 | 126 | 0 | 150 |
| Other Income | 0 | 800 | 0 | -150 | 0 |
| Pre-tax Income | -579 | 4,559 | -2,660 | 912 | -3,045 |
| Net Income Continuous | -579 | 4,559 | -2,660 | 912 | -3,045 |
| Net Income | $-579 | $4,559 | $-2,660 | $912 | $-3,045 |
| EPS Basic Total Ops | -0.02 | 0.18 | -0.10 | 0.03 | -0.12 |
| EPS Basic Continuous Ops | -0.02 | 0.18 | -0.10 | 0.03 | -0.12 |
| EPS Diluted Total Ops | -0.02 | 0.18 | -0.10 | 0.03 | -0.12 |
| EPS Diluted Continuous Ops | -0.02 | 0.18 | -0.10 | 0.03 | -0.12 |
| EBITDA(a) | $-328 | $4,087 | $-2,292 | $1,345 | $-2,695 |